CopyMark Law Group
4.9/5
Drawing for INTELLECTIVE

USPTO serial 79378706

INTELLECTIVE

Reviewed by CopyMark Law Group

Reg. 7636717Status 700Registered
Filing date
Status date
Registration date
Jan 7, 2025
Examiner
WOLFE, YOUNG J
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with INTELLECTIVE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stephanie Goeller

Stephanie Goeller Holley & MenkerPO Box 331937Atlantic Beach, FL 32233United States

Goods and services

ClassDescriptionStatusFirst use
001Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, autoimmune disorders, infectious diseases and cardiovascular, pulmonary and neurological conditions; chemicals for use in industry and science; reagents for scientific apparatus for chemical or biological analyses being reagents for scientific and research use; protein in raw material form for scientific and medical research; biochemicals for in-vitro and in-vivo scientific use; biological preparations for use in industry and science; chemical preparations for use in industry; catalysts for chemical processes; diagnostic preparations for scientific use; diagnostic reagents for science or research use; stem cells for research purposesACTIVE—
005Pharmaceutical products for treating cancer, autoimmune disorders, infectious diseases and cardiovascular, pulmonary and neurological conditions; medical preparations for the treatment of cancer, autoimmune disorders, infectious diseases and cardiovascular, pulmonary and neurological conditions; veterinary preparations for vaccinating livestock; disinfectants; preparations for destroying vermin; fungicides; herbicides; dietetic food and beverages adapted for medical use; dietetic pet foods and beverages for veterinary use; food for babies; food supplements; medical plasters, medical dressings; medicines for treating cancer, autoimmune disorders, infectious diseases and cardiovascular, pulmonary and neurological conditionsACTIVE—
042Research and development of new pharmaceutical products, such as antibodies, antibody-drug conjugates, fusion proteins and other recombinant proteins; providing information with respect to medical and scientific research in the field of pharmaceutical products; pharmaceutical research and development services; consultation with respect to pharmaceutical research; medical research; scientific research services for medical purposes in the field of pharmaceuticals; biomedical research services; scientific and medical research and development, namely, research and development in the field of medical preparations; design and development of testing and analysis methods for new pharmaceutical product development; scientific research in the nature of conducting clinical trials for others; analysis and evaluation of newly developed pharmaceutical products, such as antibodies, antibody-drug conjugates, fusion proteins and other recombinant proteins; analysis and evaluation of newly designed pharmaceutical products, such as antibodies, antibody-drug conjugates, fusion proteins and other recombinant proteins; stem cell research services; scientific research services for medical purposes in the field of proteins, antibodies, microorganisms and cells; product research; providing medical and scientific research information in the field of pharmaceutical products and clinical trials; providing information on the results of clinical research trials for pharmaceutical products; consultation with respect to pharmaceutical research and development; providing integrated development of pharmaceutical products, namely, research and development of pharmaceutical products, and scientific research in the nature of conducting clinical trials and studies for othersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 26, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 5, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 5, 2025FIMPFINAL DISPOSITION PROCESSED—
Apr 7, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 1, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Feb 12, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 12, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 7, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 7, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 19, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 19, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 13, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 5, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 16, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 16, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 16, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 13, 2024RFNTREFUSAL PROCESSED BY IB—
Apr 23, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 23, 2024RFRRREFUSAL PROCESSED BY MPU—
Apr 4, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 3, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 30, 2024RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Mar 5, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 4, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2024DOCKASSIGNED TO EXAMINER—
Dec 10, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 27, 2023CHLDCHANGE OF OWNER RECEIVED FROM IB—
Sep 19, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 15, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 14, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance